secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001437749-24-021086
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology shareholders approve 3M share increase for equity plan, elect directors
--------------------------------------------------------------------------------

- Shareholders approved amendment to increase shares under 2011 plan by 3M to 17,529,412; ISO grants extended to March 2034.
- All eight director nominees elected: Auerbach, Cesano, Dorval, Miller, Moyes, Senderowicz, Stuglik, Wilson.
- Ratified KPMG as independent auditor for fiscal 2024 with 40.2M votes for.
- Advisory say-on-pay approved with 30.7M for; board adopts annual frequency for future votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774924021086/0001437749-24-021086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774924021086/pbyi20240621_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-021086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer